Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-04
2006-04-04
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S322000, C514S394000, C546S118000, C546S199000
Reexamination Certificate
active
07022712
ABSTRACT:
A pharmaceutical composition for administration to mammals comprising: a weak base compound having a compound pKa below about 7; an acidic buffer with a buffer pKa below 7; and optional pharmaceutically acceptable additives, wherein the composition has a pH below about 4 is provided. Preferred pharmaceutically active compounds are imidazole derivatives, pyridine derivatives, and aniline derivatives. The pharmaceutical compositions have greater water solubility than the weak base.
REFERENCES:
patent: 3738995 (1973-06-01), Adams et al.
patent: 3954993 (1976-05-01), Pommer et al.
patent: 4405605 (1983-09-01), Itzel
patent: 4550174 (1985-10-01), Köch et al.
patent: 4593040 (1986-06-01), Adam et al.
patent: 4835169 (1989-05-01), Wiedmer
patent: 4980346 (1990-12-01), Balogh et al.
patent: 5124353 (1992-06-01), Clough et al.
patent: 5198444 (1993-03-01), Clough et al.
patent: 5252321 (1993-10-01), Hth et al.
patent: 5629341 (1997-05-01), Camden
patent: 5723648 (1998-03-01), Ueda
patent: 5756500 (1998-05-01), Beilfuss et al.
patent: 5767138 (1998-06-01), Camden
patent: 5880144 (1999-03-01), Camden
patent: 6077862 (2000-06-01), Camden
patent: 6194430 (2001-02-01), Camden et al.
patent: 6197805 (2001-03-01), Smith
patent: 6228400 (2001-05-01), Lee et al.
patent: 6245789 (2001-06-01), Camden
patent: 6262093 (2001-07-01), Camden
patent: 6265427 (2001-07-01), Camden
patent: 6331320 (2001-12-01), Nakahara et al.
patent: 6362207 (2002-03-01), Camden
patent: 6380232 (2002-04-01), Quada, Jr.
patent: 6384049 (2002-05-01), Camden
patent: 6407105 (2002-06-01), Quada, Jr.
patent: 6407131 (2002-06-01), Quada, Jr.
patent: 6413973 (2002-07-01), Walter et al.
patent: 6420411 (2002-07-01), Camden
patent: 6423734 (2002-07-01), Camden
patent: 6423735 (2002-07-01), Camden
patent: 6423736 (2002-07-01), Camden
patent: 6432965 (2002-08-01), Müller et al.
patent: 6462062 (2002-10-01), Camden
patent: 6479526 (2002-11-01), Camden
patent: 6482843 (2002-11-01), Quada, Jr.
patent: 6506783 (2003-01-01), Camden
patent: 6608096 (2003-08-01), Camden
patent: 6710065 (2004-03-01), Camden
patent: 2001/0027205 (2001-10-01), Camden
patent: 2002/0193609 (2002-12-01), Quada, Jr.
patent: EP 0821586 (1998-02-01), None
patent: WO 98/51304 (1998-11-01), None
patent: WO 01/12169 (2001-02-01), None
patent: WO 01/89499 (2001-11-01), None
patent: WO 01/12169 (2002-02-01), None
patent: WO 02/26716 (2002-04-01), None
patent: WO 02/41891 (2002-05-01), None
patent: WO 01/89499 (2002-07-01), None
patent: WO 02/26716 (2002-07-01), None
patent: WO 02/41891 (2003-05-01), None
Monika et. al., “Combined chromatographic techniques in pesticide residue analysis”, STN Search p. 8, 2003:381543.
Solov'eva et al. “Effect of pH on fungicidal . . . ” CA 87:112846 (1977).
Burzi et al. “High pressure . . . ” CA 95:78566 (1981).
Singh et al. “Solubility of benomyl . . . ” Ca 102:57632 (1985).
carbendazim CAS RN 10605-21-7.
Nagano et al. “Improvement of solubility of benzimidazole preparations” CA 106:133842 (1987).
Itzel “Fungicide mixtures” Ca 95:127461 (1981).
H. Brown et al.,Antiparasitic Drugs. IV. 2-(4′-Thiazolyl)-Benzimidazole, A New Anthelmintic, J. Am. Chem. Soc. 83:1764-1765, 1961.
S. Budavari, editor,The Merck Index, Merck & Co., New Jersey, Twelfth Edition, p. 291, 1996.
M. El-Sayed et al.,Combined Effect of pH Control with Surfactants or Complexants on 2-(4′-amino-3′-Methylphenyl)Benzothiazole(NSC-674495)Solubilization, Bull. Fac. Pharm. Cairo Univ. 38(2):51-56, 2000.
V. Grenda et al.,Novel Preparation of Benzimidazoles from N-Arylamidines. New Synthesis of Thiabendazole, J. Org. Chem. 30:259-261, 1965.
N. Ni et al.,Solubilization and Preformulation of Carbendazim, Int. J. Pharmaceutics 244:99-104, Sep. 2002.
Remington,Pharmaceutical Sciences, Mack Publishing Co., Easton, Pa, 17thEdition, p. 1418, 1985.
S. Yalkowsky,Solubility and Solubilization in Aqueous Media, Oxford University Press, Oxford, pp 116-396, 1999.
Arizona Board of Regents on Behalf of the University of Arizona
Chang Celia
Greenlee Winner and Sullivan P.C.
LandOfFree
Solubilization of weak bases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solubilization of weak bases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solubilization of weak bases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3589553